Pharma Grade Calcium Sulphate Market Report 2026

Pharma Grade Calcium Sulphate Market Overview

• Pharma Grade Calcium Sulphate market size has reached to $0.96 billion in 2025 • Expected to grow to $1.44 billion in 2030 at a compound annual growth rate (CAGR) of 8.4% • Growth Driver: Growing Demand For Pharmaceuticals Is Fueling The Market Growth Due To Increasing Need For High-Purity Excipients In Drug Formulations • Market Trend: Role Of Synthetic Medical-Grade Bassanite In Enhancing Product Quality • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Pharma Grade Calcium Sulphate Market?

Pharma grade calcium sulphate is a purified form of calcium sulphate (CaSO₄) specifically processed and tested to meet stringent pharmaceutical standards for use in medicines and healthcare applications. It is typically used as a diluent or excipient in tablets and capsules due to its high purity, controlled particle size, and non-toxic nature. The main types of pharma grade calcium sulphate are calcium sulphate dihydrate (CaSO₄·2H₂O), calcium sulphate hemihydrate, and calcium sulphate anhydrite. Calcium sulphate dihydrate is a pharmaceutical-grade excipient used as a binder, carrier, and controlled-release agent in drug formulations. Pharma-grade calcium sulphate is used in various applications such as pharmaceutical excipients, binders in tablet formulations, calcium supplements, and diagnostic agents. It is distributed through various channels, including direct distribution, online distribution, wholesale distribution, and retail distribution.

What Is The Pharma Grade Calcium Sulphate Market Growth Forecast?

The pharma grade calcium sulphate market size is expected to see strong growth in the next few years. It will grow to $1.44 billion in 2030 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to growth in global drug production, increasing use of high-performance excipients, rising demand for consistent formulation quality, expansion of nutraceutical manufacturing, advancements in excipient processing. Major trends in the forecast period include increasing demand for high-purity pharmaceutical excipients, growing use in tablet and capsule formulations, rising adoption in calcium supplement manufacturing, expansion of quality-controlled excipient production, increasing focus on regulatory-compliant materials.

Global Pharma Grade Calcium Sulphate Market Segmentation

1) By Type: Calcium Sulphate Dihydrate, Calcium Sulphate Hemihydrate, Calcium Sulphate Anhydrite 2) By Application: Pharmaceutical Excipients, Binders In Tablet Formulations, Calcium Supplements, Diagnostic Agents 3) By Distribution Channel: Direct Distribution, Online Distribution, Wholesale Distribution, Retail Distribution Subsegments: 1) By Calcium Sulphate Dihydrate: Fine Powder, Granular Form, Micronized Grade 2) By Calcium Sulphate Hemihydrate: Alpha Hemihydrate, Beta Hemihydrate, High Purity Hemihydrate 3) By Calcium Sulphate Anhydrite: Natural Anhydrite, Synthetic Anhydrite, High-Density Anhydrite

What Is The Driver Of The Pharma Grade Calcium Sulphate Market?

The growing demand for pharmaceuticals is expected to propel the growth of the pharma grade calcium sulphate market going forward. Pharmaceuticals refer to drugs and medications that are developed, manufactured, and used to diagnose, treat, or prevent diseases in humans and animals. The growing demand for pharmaceuticals is primarily driven by the rising prevalence of chronic diseases, as more individuals require long-term medications to manage conditions such as diabetes, cardiovascular disorders, and cancer. Pharma grade calcium sulphate enhances pharmaceutical formulations by serving as a high-purity excipient that ensures consistent tablet hardness, stability, and controlled release of active ingredients. For instance, in April 2024, according to Eurostat, a Luxembourg-based official statistical agency of the European Union, imports of medicinal and pharmaceutical products into the EU increased by 6.1% in 2023, totaling $137.4 billion (€119 billion) compared to the previous year. During the same period, EU exports reached $319.2 billion (€277 billion), resulting in a trade surplus of $182.0 billion (€158 billion). Therefore, the growing demand for pharmaceuticals is driving the growth of the pharma grade calcium sulphate industry.

Key Players In The Global Pharma Grade Calcium Sulphate Market

Major companies operating in the pharma grade calcium sulphate market are Thermo Fisher Scientific Inc., Merck KGaA, Honeywell International Inc., Avantor Inc., Spectrum Chemical Manufacturing Corp., MP Biomedicals LLC, Anhui Sunhere Pharmaceutical Excipients, Huzhou Zhanwang Pharmaceutical Co. Ltd., Loba Chemie Pvt. Ltd., SRL Chemical, GFS Chemicals Inc., American Elements, Junsei Chemical Co. Ltd., Tokyo Chemical Industry Co. Ltd., Fagron N.V., Mallinckrodt Pharmaceuticals, Ashland Global Holdings Inc., JRS Pharma, DFE Pharma, Roquette Frères

Global Pharma Grade Calcium Sulphate Market Trends and Insights

Major companies operating in the pharma grade calcium sulphate market are focusing on developing innovative products by using synthetic medical-grade bassanite to enhance the purity and consistency of calcium sulphate products. Synthetic medical-grade bassanite, a high-purity, partially dehydrated form of calcium sulphate (CaSO₄·0.5H₂O), helps produce pharma-grade calcium sulphate by providing a consistent, contaminant-free source that meets strict regulatory standards for use in medical and pharmaceutical applications. For instance, in February 2025, Sree Chitra Tirunal Institute for Medical Sciences & Technology, an India-based medical institute, launched Caspro & Bonyx, innovative drug-eluting bone graft products developed using synthetic medical-grade bassanite to ensure high purity, biocompatibility, and controlled drug delivery for advanced orthopedic applications. Caspro is a self-setting, mouldable bone cement made from calcium sulfate hemihydrate reinforced with phosphate ions, ideal for filling bone defects and delivering drugs at the site of implantation for over 21 days. Bonyx consists of osteoconductive bioceramic beads that can be vacuum-loaded with antibiotics or other medications in liquid form, enabling sustained drug release for more than 30 days. These products represent a significant step forward in localized therapy for bone infections and regeneration, demonstrating how pharma-grade calcium sulfate can be utilized in next-generation biomedical solutions that meet stringent international standards.

What Are Latest Mergers And Acquisitions In The Pharma Grade Calcium Sulphate Market?

In July 2024, Sudeep Pharma Pvt. Ltd., an India-based pharmaceutical company, acquired 50% shares of JRS Pharma GmbH + Co. KG for an undisclosed amount. With this acquisition, Sudeep Pharma aims to strengthen its leadership, accelerate innovation, and expand into emerging pharmaceutical and nutraceutical markets. JRS Pharma GmbH + Co. KG is a Germany-based pharma company that manufactures a pharmaceutical-grade calcium sulfate product called Compactrol.

Regional Insights

North America was the largest region in the pharma grade calcium sulphate market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Pharma Grade Calcium Sulphate Market?

The pharma grade calcium sulphate market consists of sales of USP-grade calcium sulfate dihydrate, anhydrous calcium sulfate, calcium sulfate hemihydrate (medical grade plaster of paris), injectable calcium sulfate pellets, and food or nutraceutical grade calcium sulfate. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Pharma Grade Calcium Sulphate Market Report 2026?

The pharma grade calcium sulphate market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pharma grade calcium sulphate industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.